ISRG Stock Recent News

Cathie Wood is built for rallying markets. The co-founder, CEO, and chief investment officer of Ark Invest is crushing the market this year, proving that she can catch 2020 in a bottle again.

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

Intuitive Surgical's Q2 gross margin declines to 67.9% as product mix shifts, new facility costs and tariffs weigh on profitability.

Intuitive Surgical (ISRG 1.46%) is one of the best success stories you'll find in the healthcare sector. The company has helped patients worldwide as a pioneer in robotic-assisted surgery, and its business success has driven the stock to returns of over 25,000% since its initial public offering (IPO) in 2000.

ISRG's Q2 procedure growth hits 17%, but continuation of EPS growth hinges on easing margin pressure from FX and da Vinci 5 adoption.

Live Updates Live Coverage Has Ended Conference Call Has Begun 4:40 pm by Eric Bleeker ISRG is set to host its earnings call on Tuesday, July 22 at 1:30 pm PDT. You can join the live webcast by registering here. What's Depressing Shares? 4:25 pm by Eric Bleeker Shares are down 3.5%. This earnings season has seen plenty of stocks posting strong earnings beats fall in after-hours trading. We can now add Intuitive Surgical to that list. The likely reason for the fall is the company projecting da Vince procedure growth at 15.5% to 17% in 2024, compared to 17% growth last quarter. Margin guidance may also be weighing on the stock in after-hours trading. More Details on Q2 4:22 pm by Eric Bleeker ISRG | Intuitive Surgical Q2’25 Earnings Highlights: Adj. EPS: $2.19 ; UP +23% YoY Revenue: $2.44B []; UP +21% YoY Adj. Gross Margin: 66.5% []; DOWN -260 bps YoY Net Income: $658M []; UP +25% YoY Outlook: The Company expects worldwide da Vinci procedure growth of approximately 15.5% to 17

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

The world's second-largest company in the healthcare equipment and supplies industry, Intuitive Surgical NASDAQ: ISRG, just reported Q2 financials. The results were solid, but not enough to move shares higher.

Intuitive Surgical's second-quarter results reflect a healthy demand for procedures on higher system utilization. However, tariffs lead to a decline in the gross margin outlook.

Here's our initial take on Intuitive Surgical's (ISRG 0.82%) financial report.